Page 8 - 80067710 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sangamo Therapeutics (NASDAQ:SGMO – Get Rating) and Innate Pharma (NASDAQ:IPHA – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk and valuation. Valuation and Earnings This table compares Sangamo Therapeutics and […]

Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Rating) has received an average recommendation of “Moderate Buy” from the seven ratings firms that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company. […]

Sangamo Therapeutics (NASDAQ:SGMO – Get Rating) and Molecular Partners (NASDAQ:MOLN – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, profitability and earnings. Insider and Institutional Ownership 59.3% of Sangamo Therapeutics shares […]

Nordea Investment Management AB increased its position in Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Rating) by 5.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 648,430 shares of the biopharmaceutical company’s stock after acquiring an additional 32,988 shares during the quarter. Nordea Investment Management […]

Sangamo Therapeutics (NASDAQ:SGMO – Get Rating) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Saturday. A number of other research firms have also recently commented on SGMO. Truist Financial dropped their target price on Sangamo Therapeutics from $23.00 to $19.00 and set a “buy” rating […]